References
Wortzel HS, Oster TJ, Anderson CA, et al. Pathological laughing and crying: epidemiology, pathophysiology and treatment. CNS Drugs 2008; 22(7): 531–45
Arciniegas DB, Topkoff J. The neuropsychiatry of pathologic affect: an approach to valuation and treatment. Semin Clin Neuro psychiatry 2000 Oct; 5(4): 290–306
Robinson RG, Parikh RM, Lipsey JR, et al. Pathological laughing and crying following stroke: validation of a measurement scale and a double-blind treatment study. Am J Psychiatry 1993 Feb; 150(2): 286–93
Muller U, Murai T, Bauer-Wittmund T, et al. Paroxetine versus citalopram treatment of pathological crying after brain injury. Brain Inj 1999 Oct; 13(10): 805–11
Nahas Z, Arlinghaus KA, Kotrla KJ, et al. Rapid response of emotional incontinence to selective serotonin reuptake inhibitors. J Neuropsychiatry Clin Neurosci 1998; 10(4): 453–5
Andersen G, Vestergaard K, Riis JO. Citalopram for post-stroke pathological crying. Lancet 1993 Oct 2; 342(8875): 837–9
Iannaccone S, Ferini-Strambi L. Pharmacologic treatment of emotional lability. Clin Neuropharmacol 1996 Dec; 19(6): 532–5
Tsai WC, Lai JS, Wang TG. Treatment of emotionalism with fluoxetine during rehabilitation. Scand J Rehabil Med 1998 Sep; 30(3): 145–9
Schiffer RB, Herndon RM, Rudick RA. Treatment of pathologic laughing and weeping with amitriptyline. N Engl J Med 1985; 312(23): 1480–2
Schiffer RB, Cash J, Herndon RM. Treatment of emotional lability with low-dosage tricyclic antidepressants. Psychosomatics 1983 Dec; 24(12): 1094–6
de Oliveira-Souza R, de Figueiredo WM, Andreiuolo PA. Pathological crying and unilateral pontine infarction [in Portuguese]. Arq Neuropsiquiatr 1995 Sep; 53(3-B): 680–9
Rabins PV, Arciniegas DB. Pathophysiology of involuntary emotional expression disorder. CNS Spectr 2007 Apr; 12(4 Suppl. 5): 17–22
Linner L, Wiker C, Arborelius L, et al. Selective noradrenaline reuptake inhibition enhances serotonergic neuronal activity and transmitter release in the rat forebrain. J Neural Transm 2004 Feb; 111(2): 127–39
Evans RW, Gualtieri CT, Patterson D. Treatment of chronic closed head injury with psychostimulant drugs: a controlled case study and an appropriate evaluation procedure. J Nerv Ment Dis 1987 Feb; 175(2): 106–10
Brooks BR, Thisted RA, Appel SH, et al. Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: a randomized trial. Neurology 2004 Oct 26; 63(8): 1364–70
Panitch HS, Thisted RA, Smith RA, et al. Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis. Ann Neurol 2006 May; 59(5): 780–7
Udaka F, Yamao S, Nagata H, et al. Pathologic laughing and crying treated with levodopa. Arch Neurol 1984 Oct; 41(10): 1095–6
Rights and permissions
About this article
Cite this article
Pathological laughing and crying may be caused by many neurological disorders and is highly responsive to treatment. Drugs Ther. Perspect 25, 18–20 (2009). https://doi.org/10.2165/0042310-200925040-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/0042310-200925040-00006